Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

ClinicalTrials.gov ID: NCT01262651

Public ClinicalTrials.gov record NCT01262651. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double Blind, Randomized, Placebo-controlled, Parallel Group Study of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 9-week study aimed to determine the efficacy, safety and tolerability of nabiximols (Sativex®) as an adjunctive treatment, compared with placebo in relieving uncontrolled persistent chronic pain in participants with advanced cancer. Eligible participants were not required to stop any of their current treatments or medications.

Study identification

NCT ID
NCT01262651
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GW Pharmaceuticals Ltd
Industry
Enrollment
397 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 25, 2010 (Actual)
Primary completion
Jul 2, 2015 (Actual)
Completion
Jul 2, 2015 (Actual)
Last update posted
Apr 23, 2018

2010 – 2015

United States locations

U.S. sites
25
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
Not listed Phoenix Arizona 85027 —
Not listed Phoenix Arizona 85028 —
Not listed El Cajon California 92020 —
Not listed Gilroy California 95020 —
Not listed Brandon Florida 33511 —
Not listed Daytona Beach Florida 32117 —
Not listed Holiday Florida 34691 —
Not listed Jacksonville Florida 32257 —
Not listed Lynn Haven Florida 32444 —
Not listed Stuart Florida 34994 —
Not listed Winter Park Florida 32789 —
Not listed Newnan Georgia 30265 —
Not listed Stockbridge Georgia 30281 —
Not listed Shreveport Louisiana 71105 —
Not listed Saint Louis Park Minnesota 55426 —
Not listed Kansas City Missouri 64132 —
Not listed Berlin New Jersey 08009 —
Not listed Hendersonville North Carolina 28739 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Philadelphia Pennsylvania 19146 —
Not listed Houston Texas 77024 —
Not listed Houston Texas 77089 —
Not listed Laredo Texas 78041 —
Not listed Salt Lake City Utah 84112 —
Not listed Salt Lake City Utah 84124 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01262651, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2018 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01262651 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →